Trials / Completed
CompletedNCT06348095
Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia
Effect of Probiotic WecProB on the Course of Mycoplasma Pneumoniae Pneumonia in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 6 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness and safety of compound probiotic in shortening the course of illness in children with mycoplasma pneumoniae pneumonia, in comparison with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | The experimental phase of this study had last 14 days, and each patient will make 4 visits (d0, at discharge, d14). |
| DIETARY_SUPPLEMENT | Placebo | The experimental phase of this study had last 14 days, and each patient will make 4 visits (d0, at discharge, d14). |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-03-20
- Completion
- 2025-08-31
- First posted
- 2024-04-04
- Last updated
- 2026-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06348095. Inclusion in this directory is not an endorsement.